MicuRx Pharmaceuticals, Inc.

MicuRx Pharmaceuticals, Inc.

MicuRx Pharmaceuticals, Inc.

MicuRx is a clinicalstage biopharmaceutical company developing innovative antibiotics for multidrugresistant (MDR) bacterial infections including MRSA and VRE..
Type
B2b
Founded
2007
Raised
$133M
Follow us
Alexa global traffic share
Latest funding Show all
$43,000,000
Venture capital (Series D) - 2020
Huagai Capital Zero2IPO Asset Management Sinopharm-CICC Medical & Healthcare Investment Management
$55,000,000
Venture capital (Series C) - 2016
GP Healthcare Capital GP TMT Capital 3E Bioventures Capital +3
Team Size
10+
Employees
$43,000,000 Venture capital (Series D)
AVCJ

Huagai leads $43m round for China antibiotics developer

ChinaMoneyNetwork

HG Capital Leads Series D Round In MicuRx Pharmaceuticals – China Money Network

$55,000,000 Venture capital (Series C)
yahoo , FinSMEs , prnasia

MicuRx Closes $55 Million Series C Financing to Support Development of Next-Generation Antibiotic MRX-I

Health